Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Biochemical and Biophysical Research CommunicationsOpen Access

RNA drugs and nonviral nanocarriers in oncology – present status and emerging concepts

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAchim Aigner

Discussion

Loading...

Member takes

Overview

This review highlights issues in RNA delivery and outlines various RNA classes in oncology, suggesting novel approaches for therapy.

Key Points

  • RNA therapeutics offer innovative strategies in oncology, but face challenges in stability and pharmacokinetics.
  • Non-viral nanoparticle formulations play a crucial role in enhancing RNA delivery and cellular uptake.
  • Various classes of RNA, such as siRNA and mRNA, are being explored as drug candidates targeting pathological processes.
  • Efficient systems for RNA delivery are vital to translate these therapies into clinical practice.

Cite This Study

Achim Aigner (2025) studied this question.

synapsesocial.com/papers/68c1c9dd54b1d3bfb60f3140https://doi.org/10.1016/j.bbrc.2025.152512
View Full Paper
Ask AI
Bookmark
Share